From the moment you turn off your morning alarm, to the time you hit the pillow, your life is full of surfaces. Swiping through your phone, opening doors, putting in your PIN – there are many you don’t think twice about touching.
But SARS-CoV-2, the virus that causes COVID-19, will likely change the way we all think about, and interact with, surfaces forever. Our peer-reviewed study published in Virology Journal reveals new information about the virus and how it behaves on surfaces.
Understanding SARS-CoV-2 on surfaces
From analysing sewage to testing face masks, our research has been contributing to the global battle against COVID-19.
At this stage of the pandemic, researchers do not fully understand the role contaminated surfaces play in the transmission of SARS-CoV-2. To improve our understanding of how this new virus behaves, our researchers studied the survival rates of infectious SARS-CoV-2, dried in an artificial mucous solution, on six common surfaces.
We conducted the experiment at three different temperatures, 200C, 300C and 400C, with the relative humidity kept at 50 per cent. The surfaces used in the study were stainless steel, glass, vinyl, paper and polymer banknotes, and cotton cloth. These are examples of high contact surface areas such as glass on touchscreens and stainless steel doorknobs.
A droplet of fluid containing the virus at concentrations similar to levels observed in infected patients was dried on multiple small test surfaces and left for up to 28 days. At various time periods, the virus was recovered and placed in tissue culture cells to observe if any infectious virus remained.
Impact of temperature on virus
At 20°C, the virus was extremely robust. We were able to recover infectious material after 28 days from the smooth (non-porous) surfaces. These are stainless steel, glass, vinyl and paper and polymer banknotes.
The length of time infectious virus was able to survive on the porous material (cotton cloth) was much shorter. On cloth, we were unable to detect any viable virus past 14 days.
At 30°C infectious virus did not survive beyond seven days on stainless steel, money (polymer banknotes) and glass. However, on vinyl and cotton cloth, infectious material was not detectable beyond three days.
At 40°C virus was inactivated much faster. Infectious SARS-CoV-2 was detectable for less than 16 hours for cotton cloth. While on glass, paper and polymer notes, and stainless steel it was detectable for up to 24 hours, and 48 hours for vinyl.
Infographic explaining COVID-19 on surfaces.
How long SARS-CoV-2 survived on five different surfaces at three temperatures, 20°C, 30°C and 40°C.
How many particles can cause an infection?
It generally takes more than one virus particle to infect a person and make them sick. We call the number of virus particles that can cause infection the “infectious dose”. This dosage differs between different viruses and is usually quite large.
Researchers do not yet know the infectious dose of SARS-CoV-2. But, from our knowledge of related viruses, we estimate it is around 300 particles. If the virus was placed (on smooth surfaces) at standard mucus concentrations of an infected person, enough virus would easily survive for two weeks to be able to infect another person.
Further research on this topic is necessary. However, our findings indicate the 28-day sample would not contain enough viable virus to infect a person.
Whether virus particles on a surface can infect someone is dependent on several conditions. Outside of the body, SARS-CoV-2 virus particles gradually become inactive over time. The time it takes for viruses to naturally inactivate depends on many factors. The makeup of the virus itself, the type of surface it is on and whether the virus is liquid or dried can impact the time it remains viable. Environmental conditions such as temperature, exposure to sunlight and humidity also play a part.
Image Credit: Australian Centre for Disease Preparedness (ACDP)
ANSTO has contributed to a comprehensive investigation of a promising type of nanoparticle that could potentially be used for intractable brain cancers in a combined therapy. The study, which was led by Dr. Moeava [...]
The immune response needed to protect people against reinfection with the coronavirus will be explored in a new human challenge trial, researchers have revealed. Human challenge trials involve deliberately exposing healthy people to a [...]
Researchers from Duke University are developing a flu shot with the new technology that was used for two coronavirus vaccines. Both the Pfizer-BioNTech and the Moderna shots use part of the virus's genetic code [...]
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19. In a paper published in the journal Nanoscale, [...]
Researchers have developed a new superbug-destroying coating that could be used on wound dressings and implants to prevent and treat potentially deadly bacterial and fungal infections. The material is one of the thinnest antimicrobial [...]
The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In a joint statement Tuesday, the Centers for Disease Control [...]
The South African coronavirus variant is better at "breaking through" the defences of the Pfizer/BioNTech vaccine than other forms of the virus, Israeli experts said Sunday. However, one of the authors told AFP that [...]
EPFL scientists have developed AI-powered nanosensors that let researchers track various kinds of biological molecules without disturbing them. The tiny world of biomolecules is rich in fascinating interactions between a plethora of different agents [...]
A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation of the cellular [...]
Researchers at Brown University have succeeded in creating the first wireless, implantable, rechargeable, long-term brain-computer interface. The wireless BCIs have been implanted in pigs and monkeys for over 13 months without issue, and human [...]
The coronavirus outbreak made household names of companies like Moderna Inc. and BioNTech SE, whose shots offered hope for ending the pandemic. Now a new wave of vaccines is on the horizon that may get the [...]
Researchers at the University of Southampton have developed a new way of using nanomaterials to identify and enrich skeletal stem cells—a discovery which could eventually lead to new treatments for major bone fractures and [...]
In March 2020, Hannu Rajaniemi pivoted his biotech company Helix Nanotechnologies' focus from cancer therapies to Covid-19 vaccines. The role biotech start-ups can play in a pandemic Rajaniemi originally co-founded Helix Nanotechnologies in Cambridge, Massachusetts in [...]
The rapid mass testing strategy costing just £1 a day per child can get children back to school and economies up and running, according to experts. That is the small price of the [...]
Covid-19 vaccines are incredibly good at preventing severe symptoms and hospitalization, but they’re probably less effective at stopping transmission. To do that, we might need a different kind of vaccine altogether. Because SARS-CoV-2 is [...]
For many scientists, challenging the idea that SARS-CoV-2 has natural origins is seen as career suicide. But a vocal few say it shouldn't be disregarded or lumped in with conspiracy theories. Nikolai Petrovsky was scrolling [...]